TargetMol® offers 20,000+ inhibitor & agonists, widely applied in key research areas like cancer, diabetes, endocrine, nervous system, and metabolism.
Compound Libraries | Inhibitors & Agonists | Natural Products | Recombinant Proteins | Custom Compound Synthesis
TargetMol Chemicals Inc. is headquartered in the Greater Boston area, MA, and specializes in products and services that serve the research needs of chemical and biological scientists worldwide. With a client base in 50+ countries, TargetMol has evolved into one of the biggest global research suppliers for compound libraries and inhibitors & agonists.
| PI3k/Akt/mTOR Signaling |
| RNA-3236 (T5993) |
| Rapamycin (T1537) |
| Salidroside (T2717) |
| Alpelisib (T1921) |
| MK-2206 dihydrochloride (T1952) |
| Angiogenesis |
| Lenvatinib (T0520) |
| Orelabrutinib (T12317) |
| Pexidartinib (T2115) |
| Crenolanib (T2677) |
| Amuvatinib (T2516) |
| Proteases/Proteasome |
| GK921 (T3968) |
| Leupeptin Hemisulfate (T6564) |
| Z-IETD-FMK (T7019) |
| Azvudine (T14489) |
| Z-YVAD-FMK (TP1466) |
| Stem Cells |
| RKI-1447 (T1898) |
| XAV-939 (T1878) |
| CHIR-99021 (T2310) |
| Verteporfin (T3112) |
| Y-27632 dihydrochloride (T1725) |
| Cell Cycle/Checkpoint |
| Adavosertib (T2077) |
| Palbociclib (T1785) |
| PF-06873600 (T8463) |
| COH29 (T3157) |
| Abemaciclib (T2381) |
| DNA Damage/DNA Repair |
| Bleomycin Sulfate (T6116) |
| Branaplam (T4641) |
| Ceralasertib (T3338) |
| Cisplatin (T1564) |
| Oxaliplatin (T0164) |
Compound Libraries | Inhibitors & Agonists | Natural Products | Recombinant Proteins | Custom Compound Synthesis
We gladly support you by keeping you updated on our latest products and developments
